NuVasive merger with Globus Medical approved by shareholders

• NuVasive (NASDAQ:NUVA) shareholders have approved the company's planned merger with Globus Medical (GMED).
• Terms call for NuVasive shareholders to receive 0.75 of a share of Globus Medical (GMED) common stock for each share of NuVasive (NUVA).
• The deal has an equity value of ~$3B.

More on the Nuvasive/Globus merger

• Globus Medical: Does The NuVasive Merger Make Sense?

• Globus And NuVasive Take Spinal Fusion To A New Level

• Globus Medical: Back Pains